Product Profile
Supports Baby's Intestinal Health
Baby’s Jarro-Dophilus® contains superior, scientifically documented strains. Clinical studies have documented the benefits of B. breve M-16V and B. longum BB536 (Morinaga) in infants and young children. All probiotic strains in Baby’s Jarro-Dophilus® produce L+ lactic acid which is especially ideal for babies. The dominant intestinal flora of infants are the bifidobacteria, which is why Baby’s Jarro-Dophilus® contains a higher percentage of bifidobacteria than lactobacilli. Baby’s Jarro-Dophilus® contains Inulin-FOS (FructoOligoSaccharides) to encourage growth of beneficial flora.*
| B. breve M-16V* | 25% | 750 Million |
| B. lactis Bi-07 (formerly B. infantis) | 15% | 450 Million |
| B. longum BB536* | 15% | 450 Million |
| B. bifidum Bb-02 | 15% | 450 Million |
| L. casei R0215 | 15% | 450 Million |
| L. rhamnosus Lr-32 | 15% | 450 Million |
| Total | 3 Billion | |
Keep Refrigerated
Item Size
70 gm
Nutrition
 |
 | ||||||||||||||
| ||||||||||||||
STORE HOURS | ||||||||||||||
| ||||||||||||||
 |
|
 |
|
 |
|
|
 |
|
|
All contents © Copyright 1999-2013 Living Naturally and Health Foods Unlimited. All rights reserved. This internet site is hosted by Living Naturally, a Web site service provider to natural health stores nationwide. Living Naturally and Health Foods Unlimited have no means of independently evaluating the safety or functionality of the products offered by their suppliers and affiliates and thus can neither endorse nor recommend products. Information presented is of a general nature for educational and informational purposes only. Statements about products and health conditions have not been evaluated by the US Food and Drug Administration. Products and information presented herein are not intended to diagnose, treat, cure, or prevent disease. If you have any concerns about your own health, you should always consult with a physician or other healthcare professional. Your use of this site indicates your agreement to be bound by our Terms and Conditions
